Fielmann AG
OTC:FLMNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fielmann AG
OTC:FLMNF
|
DE |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
FINEOS Corporation Holdings PLC
ASX:FCL
|
IE |
|
U
|
Universal Music Group NV
VSE:UMG
|
NL |
|
Ondas Holdings Inc
NASDAQ:ONDS
|
US |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
Wall St Price Targets
FLMNF Price Targets Summary
Fielmann AG
According to Wall Street analysts, the average 1-year price target for FLMNF is 65.43 USD with a low forecast of 57.72 USD and a high forecast of 78.01 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FLMNF's stock price target?
Price Target
65.43
USD
According to Wall Street analysts, the average 1-year price target for FLMNF is 65.43 USD with a low forecast of 57.72 USD and a high forecast of 78.01 USD.
What is the Revenue forecast for Fielmann AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Fielmann AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Fielmann AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 12%.
